James Weaver, Charmine C Williams, Notisha Massaquoi
Assessed HIV vaccine acceptability and correlates of acceptability
Black women from African and Caribbean communities
Mean vaccine acceptability was 58.8 (SD=17.2) on the 100-point scale. Efficacy had the greatest impact on acceptability, followed by side effects, cost, duration of protection, and number of doses. Acceptability of a high (99%) efficacy vaccine (70.1/100) was significantly greater than for a 50% efficacy vaccine (47.6/100). Vaccine acceptability was significantly higher among women of Caribbean versus African descent, ever married versus single women, and women with full-time versus part-time employment. Black women in Toronto indicated a modest level of acceptability for future HIV vaccines. Differences in acceptability within Black communities suggest that tailored multi-level interventions may mitigate barriers to uptake.